Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothEtodolac 400mg
Etova ER 400mg Tablet PR 10s
You Searched
Etova ER 400mg Tablet PR 10s
Ipca Laboratories Ltd.
₹192.5
Our Recommendation
Etolgia 400mg Tablet XR 10s
2+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Pain relief
Customers also bought
More About Etova
Benefits
In Pain relief Etova-ER 400 Tablet PR belongs to a group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs). It is used for short-term relief of pain, inflammation, and swelling in conditions that affect joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis. To obtain the maximum benefit, follow the prescribed instructions precisely. Do not take more or for longer than needed as that can be dangerous. In general, you should take the lowest dose that works, for the shortest possible time. This will help you to go about your daily activities more easily and have a better, more active, quality of life.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Use it as advised by your doctor or check the label for directions before use. Etova-ER 400 Tablet PR is to be taken with food.
How it works
Etova-ER 400 Tablet PR is a non-steroidal anti-inflammatory drugs (NSAID). It works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling).
Unsafe: Avoid consuming alcohol with Etova-ER 400 Tablet PR as it is deemed unsafe.
Seek medical advice from your doctor: Etova-ER 400 Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Etova-ER 400 Tablet PR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: Etova-ER 400 Tablet PR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Safe when prescribed by an expert: Etova-ER 400 Tablet PR is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Etova-ER 400 Tablet PR may not be needed in these patients. Doctor consultation is advised. Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Seek medical advice from your doctor: There is limited information available on the use of Etova-ER 400 Tablet PR in patients with liver disease. Doctor consultation is advised.
What if I forget to take it?
If a dose of Etova-ER 400 Tablet PR is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra
References
Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 627
Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 985-86
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 518
Etodolac. Princeton, New Jersey: Aesgen Inc.; 1997 (02 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (02 Apr. 2019)
Etodolac (25 Jul. 2024)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
